{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:56:01Z","timestamp":1780667761314,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.arcmed.2006.09.006","type":"journal-article","created":{"date-parts":[[2006,12,15]],"date-time":"2006-12-15T07:25:57Z","timestamp":1166167557000},"page":"15-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Reversal Effect of Thalidomide on Established Hepatic Cirrhosis in Rats via Inhibition of Nuclear Factor-\u03baB\/Inhibitor of Nuclear Factor-\u03baB Pathway"],"prefix":"10.1016","volume":"38","author":[{"given":"Peng","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Sheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jv","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley Chireyath","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Min","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2006.09.006_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/scbi.1997.0057","article-title":"Rel\/NF-\u03baB and I \u03baB proteins: an overview","volume":"8","author":"May","year":"1997","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.arcmed.2006.09.006_bib2","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1074\/jbc.M209995200","article-title":"NF-\u03baB and I \u03baB \u03b1 are found in the mitochondria. Evidence for regulation of mitochondrial gene expression by NF-\u03baB","volume":"278","author":"Cogswell","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.arcmed.2006.09.006_bib3","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nature03491","article-title":"IKK \u03b1 limits macrophage NF-\u03baB activation and contributes to the resolution of inflammation","volume":"434","author":"Lawrence","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2006.09.006_bib4","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1172\/JCI26322","article-title":"IKK\/NF-\u03baB signaling: balancing life and death\u2013a new approach to cancer therapy","volume":"115","author":"Luo","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2006.09.006_bib5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/hep.510300327","article-title":"Persistent activation of nuclear factor-\u03baB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins","volume":"30","author":"Elsharkawy","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.006_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1053\/gast.2001.27188","article-title":"Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats","volume":"121","author":"Wright","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.006_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2004.10.003","article-title":"Inhibition of inhibitor of \u03baB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis","volume":"128","author":"Oakley","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.006_bib8","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/jhep.2003.50182","article-title":"Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells","volume":"37","author":"Paik","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.006_bib9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00063030-200115100-00005","article-title":"Theoretical basis for the activity of thalidomide","volume":"15","author":"Meierhofer","year":"2001","journal-title":"BioDrugs"},{"key":"10.1016\/j.arcmed.2006.09.006_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s002280100320","article-title":"Clinical pharmacology of thalidomide","volume":"57","author":"Eriksson","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.arcmed.2006.09.006_bib11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0149-2918(03)80085-1","article-title":"Thalidomide: a review of approved and investigational uses","volume":"25","author":"Matthews","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.arcmed.2006.09.006_bib12","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","article-title":"Thalidomide","volume":"363","author":"Franks","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2006.09.006_bib13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00042737-200309000-00003","article-title":"Thalidomide ameliorates carbon tetrachloride induced cirrhosis in the rat","volume":"15","author":"Muriel","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.006_bib14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jhep.2004.06.019","article-title":"Thalidomide salvages lethal hepatic necroinflammation and accelerates recovery from cirrhosis in rats","volume":"41","author":"Yeh","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.006_bib15","doi-asserted-by":"crossref","first-page":"22382","DOI":"10.1074\/jbc.M100938200","article-title":"Inhibition of NF-k B activity by thalidomide through suppression of Ikappa B kinase activity","volume":"276","author":"Keifer","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2006.09.006_bib16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.006_bib17","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/hep.510280512","article-title":"Fibrosis accelerates the development of enzyme-altered lesions in the rat liver","volume":"28","author":"Sakaida","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.006_bib18","first-page":"65","article-title":"Determination of keratin protein in a tape-stripped skin sample from jet fuel exposed skin","volume":"48","author":"Chao","year":"2004","journal-title":"Ann Occup Hyg"},{"key":"10.1016\/j.arcmed.2006.09.006_bib19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0731-7085(03)00312-1","article-title":"RNA extraction for quantitative enterovirus RT-PCR: comparison of three methods","volume":"33","author":"Verheyden","year":"2003","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.arcmed.2006.09.006_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403005684","article-title":"Molecular basis of hepatic fibrosis","volume":"2003","author":"Hui","year":"2003","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.arcmed.2006.09.006_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2001-17550","article-title":"History, heterogeneity, developmental biology functions of quiescent hepatic stellate cells","volume":"21","author":"Geerts","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.arcmed.2006.09.006_bib22","doi-asserted-by":"crossref","first-page":"d808","DOI":"10.2741\/reeves","article-title":"Activation of hepatic stellate cells\u2014a key issue in liver fibrosis","volume":"7","author":"Reeves","year":"2002","journal-title":"Front Biosci"},{"key":"10.1016\/j.arcmed.2006.09.006_bib23","first-page":"438","article-title":"Hepatic stellate cells (HSC): architects of hepatic fibrosis","volume":"95","author":"Solis-Herruzo","year":"2003","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.arcmed.2006.09.006_bib24","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1111\/j.1572-0241.2001.05289.x","article-title":"Thalidomide-induced normalization of serum ALT levels in a patient with hepatitis C","volume":"96","author":"Raufman","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.006_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0014-2999(02)02423-8","article-title":"Cytokine modulation and suppression of liver injury by a novel analogue of thalidomide","volume":"453","author":"Thiele","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"suppl","key":"10.1016\/j.arcmed.2006.09.006_bib26","first-page":"2S","article-title":"Protective effect of thalidomide on endotoxin-induced liver injury","volume":"27","author":"Enomoto","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.arcmed.2006.09.006_bib27","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.bcp.2004.06.018","article-title":"Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat","volume":"68","author":"Fernandez-Martinez","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.arcmed.2006.09.006_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2036.2003.01809.x","article-title":"A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis","volume":"19","author":"Austin","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2006.09.006_bib29","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/cncr.20821","article-title":"Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial","volume":"103","author":"Patt","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.arcmed.2006.09.006_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hep.1840120110","article-title":"Immunohistochemical study of adhesion molecules in liver inflammation","volume":"12","author":"Volpes","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.006_bib31","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1023\/A:1015393708187","article-title":"Serum intercellular adhesion molecule-I in children with chronic liver disease: relationship to disease activity","volume":"47","author":"Abdalla","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.arcmed.2006.09.006_bib32","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2169\/internalmedicine.42.947","article-title":"Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 protein and messenger RNA in primary biliary cirrhosis","volume":"42","author":"Yokomori","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.arcmed.2006.09.006_bib33","first-page":"794","article-title":"Serum levels of intercellular adhesion molecule-1 and nitric oxide in patients with chronic hepatitis related to hepatitis C virus: connection fibrosis","volume":"50","author":"Pata","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.006_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/00365520510011470","article-title":"Adhesion molecules as a prognostic marker of liver cirrhosis","volume":"40","author":"Giron-Gonzalez","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.006_bib35","first-page":"1105","article-title":"Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-\u03b1 agent thalidomide","volume":"47","author":"Settles","year":"2001","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.arcmed.2006.09.006_bib36","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/hep.510270514","article-title":"Inhibition of NF-\u03ba B in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor","volume":"27","author":"Hellerbrand","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.006_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbrc.2004.10.020","article-title":"LPS-mediated NF-k B activation varies between activated human hepatic stellate cells from different donors","volume":"325","author":"Muhlbauer","year":"2004","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844090600333X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844090600333X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:32:34Z","timestamp":1759260754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018844090600333X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S018844090600333X"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2006.09.006","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal Effect of Thalidomide on Established Hepatic Cirrhosis in Rats via Inhibition of Nuclear Factor-\u03baB\/Inhibitor of Nuclear Factor-\u03baB Pathway","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2006.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}